Back
Xylem Vs. Apellis Pharmaceuticals Industry Stock Comparison
Sell
41
XYL
Xylem
Last Price:
140.89
Seasonality Move:
2.18%
Sell
34
APLS
Apellis Pharmaceuticals
Last Price:
39.81
Seasonality Move:
-5.11%
Sell
41
Xylem (XYL)
is a Sell
Is Xylem a Buy, Sell or Hold?
- The current Xylem [XYL] share price is $137.13. The Score for XYL is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- XYL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $38.88. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
XYL Stock Price Chart
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $38.88
The current trend is relatively stagnant and APLS is experiencing slight buying pressure.
XYL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.26 | Buy |
| Relative Strength Index (14 RSI): | 48.91 | Sell |
| Chaikin Money Flow: | -446094 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (134.28 - 139.28) | Buy |
| Bollinger Bands (100): | (128.78 - 140.42) | Buy |
APLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.6 | Sell |
| Relative Strength Index (14 RSI): | 50.1 | Buy |
| Chaikin Money Flow: | 536240 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.59 - 39.97) | Buy |
| Bollinger Bands (100): | (38.43 - 54.53) | Sell |
XYL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 138.71 | Sell |
| 20-day SMA: | 136.5 | Buy |
| 50-day SMA: | 138.83 | Sell |
| 200-day SMA: | 121.17 | Buy |
| 8-day EMA: | 138 | Sell |
| 20-day EMA: | 137.62 | Sell |
| 50-day EMA: | 136.93 | Buy |
| 200-day EMA: | 125.35 | Buy |
APLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.35 | Buy |
| 20-day SMA: | 38 | Buy |
| 50-day SMA: | 39.79 | Sell |
| 200-day SMA: | 52.12 | Sell |
| 8-day EMA: | 38.1 | Buy |
| 20-day EMA: | 38.47 | Buy |
| 50-day EMA: | 40.79 | Sell |
| 200-day EMA: | 49.63 | Sell |
Xylem Earnings Growth & XYL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.06 per share, an increase this year of $0.48 per share, and an increase next year of $0.54 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.88 per share, an increase next quarter of $0.27 per share, an increase this year of $3.51 per share, and an increase next year of $1.98 per share.
Xylem Technical Analysis
| Jul 12 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 19 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Apellis Pharmaceuticals Technical Analysis
| Jul 12 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 19 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||